Biomedical Engineering Reference
In-Depth Information
47. Apostolovic, B., et al.,
Hybrid polymer therapeutics incorporating
bioresponsive, coiled coil peptide linkers.
Biomacromolecules, 2010.
11
(5): p. 1187-1195.
48. Strebhardt, K. and A. Ullrich,
Paul Ehrlich's magic bullet concept: 100
years of progress.
Nat Rev Cancer, 2008.
8
(6): p. 473-480.
49. Parveen, S. and S.K. Sahoo,
Polymeric nanoparticles for cancer therapy.
J Drug Target, 2008.
16
(2): p. 108-123.
50. Ishida, T., et al.,
Targeted delivery and triggered release of liposomal
doxorubicin enhances cytotoxicity against human B lymphoma cells.
Biochim Biophys Acta, 2001.
1515
(2): p. 144-158.
51. Ryppa, C., et al.,
In vitro and in vivo evaluation of a paclitaxel conjugate
with the divalent peptide E-[c(RGDfK)2] that targets integrin alpha v
beta 3.
Int J Pharm, 2009.
368
(1-2): p. 89-97.
52. Polyak, D., et al.,
Development of PEGylated doxorubicin-E-[c(RGDfK)2]
conjugate for integrin-targeted cancer therapy.
Polym. Adv. Technol.,
2011.
22
: p. 103-113.
53. Kaneshiro, T.L. and Z.R. Lu,
Targeted intracellular codelivery of
chemotherapeutics and nucleic acid with a well-defined dendrimer-based
nanoglobular carrier.
Biomaterials, 2009.
30
(29): p. 5660-5666.
54. Oba, M., et al.,
Cyclic RGD peptide-conjugated polyplex micelles as a
targetable gene delivery system directed to cells possessing alphavbeta3
and alphavbeta5 integrins.
Bioconjug Chem, 2007.
18
(5): p. 1415-
1423.
55. Arnaout, M.A., S.L. Goodman, and J.P. Xiong,
Coming to grips with
integrin binding to ligands.
Curr Opin Cell Biol, 2002.
14
(5): p. 641-
651.
56. Adar, L., et al.,
Pro-apoptotic peptide-polymer conjugates to induce
mitochondrial-dependent cell death.
Polym Adv Technol,
in press
,
2010.
57. Gragoudas, E.S., et al.,
Pegaptanib for neovascular age-related macular
degeneration.
N Engl J Med, 2004.
351
(27): p. 2805-2816.
58. Milane, L.J., Z. Duan, and M.M. Amiji,
Development of EGFR-targeted
polymer blend nanocarriers for Paclitaxel/Lonidamine delivery to treat
multi-drug resistance in human breast and ovarian tumor cells.
Mol
Pharm, 2010.
8
(1): p. 185-203.
59. Shamay, Y., et al.,
E-selectin binding peptide-polymer-drug conjugates
and their selective cytotoxicity against vascular endothelial cells.
Biomaterials, 2009.
30
(32): p. 6460-6468.
60. Kneuer, C., et al.,
Selectins — potential pharmacological targets?
Drug
Discov Today, 2006.
11
(21-22): p. 1034-1040.
Search WWH ::
Custom Search